U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501234) titled 'Safety and Feasibility Study of the MitraFix(R) Transcatheter Mitral Valve System' on March 19.
Brief Summary: The goal of this early feasibility clinical trial is to test a new device called the MitraFix(R) Transcatheter Mitral Valve System. It aims to learn if the device is safe and if it can help adults who have a severe leaky heart valve (mitral regurgitation). This study is for people who are at high risk for traditional open-heart surgery.
The main questions it aims to answer are:
Is the MitraFix system safe for participants? Can the device be successfully placed in the heart? Does the device help reduce the valve leak and ...